Detalles de la búsqueda
1.
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
J Autoimmun;
131: 102866, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35841684
2.
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
J Autoimmun;
125: 102744, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781162
3.
Magnetic Resonance Imaging of Primary Adult Brain Tumors: State of the Art and Future Perspectives.
Biomedicines;
11(2)2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36830900
4.
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group.
RMD Open;
9(2)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37328292
5.
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.
J Transl Autoimmun;
7: 100212, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854035
6.
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies.
Curr Pharm Des;
28(24): 2022-2028, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35726427
7.
Regorafenib in Glioblastoma Recurrence: How to Deal With MR Imaging Treatments Changes.
Front Radiol;
1: 790456, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492166
8.
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments.
Curr Pharm Des;
27(41): 4245-4252, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34477509
9.
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series.
Clin Rheumatol;
39(11): 3195-3204, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852623
10.
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
PLoS One;
13(10): e0205134, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30356301
11.
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study.
Lancet Rheumatol;
3(3): e166-e168, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33521657
Resultados
1 -
11
de 11
1
Próxima >
>>